Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer
Luisa Klemke(Universitätsmedizin Göttingen), Ramona Schulz‐Heddergott(Universitätsmedizin Göttingen)
Cited by 109
Related Papers
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition
|Cell Death and Differentiation|2025|9
Targeting macrophage migration inhibitory factor as a potential therapeutic strategy in colorectal cancer
|Oncogenesis|2025|5
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition
|bioRxiv (Cold Spring Harbor Laboratory)|2024|1
HSP90-stabilized proteins as therapeutic targets in cancer
|Unknown|2021|0